- Home
- SHMD vs VOR Comparison
SHMD vs VOR Comparison
Compare SHMD & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SHMD | VOR |
|---|---|---|
| Founded | 1864 | 2015 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.7M | 207.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SHMD | VOR |
|---|---|---|
| Price | $4.29 | $13.21 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $67.00 |
| AVG Volume (30 Days) | 174.9K | ★ 3.4M |
| Earning Date | 01-01-0001 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $85,165,542.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.86 | $2.62 |
| 52 Week High | $6.70 | $65.80 |
Technical Indicators
Market Signals| Indicator | SHMD | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 51.95 |
| Support Level | $3.87 | $7.91 |
| Resistance Level | $5.47 | $16.80 |
| Average True Range (ATR) | 0.66 | 1.66 |
| MACD | -0.08 | 1.19 |
| Stochastic Oscillator | 24.38 | 62.04 |
Price Performance
Historical ComparisonAbout SHMD SCHMID Group N.V. Class A Ordinary Shares
Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.